August 2008 Oncology News International

News
Article

Cover Story

  • High cost of biologics takes a toll on hem/onc practices
  • FDA cracks down on counterfeit cancer cure products

DEPARTMENTS

Focus on Breast Cancer

  • Mastectomy rates for early breast cancer are on the upswing at one Mayo Clinic
  • Is breast MRI primed for widespread use as a high-risk screening tool?
  • Vantage Point: Risk factors will guide the imaging paradigm

Focus on Lung Cancer

  • Anti-IGF-1R antibody plus chemo active in advanced non-small-cell lung cancer

News & Analysis

  • Oncologic drug safety: Separating fact from fiction

Focus on Prostate Cancer

  • Dual antiangiogenic therapy plus chemo is active in advanced prostate cancer

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.
2 experts in this video